|
Malignant neoplasm of breast
|
0.360 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
|
Chest Pain
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Coughing
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Nausea and vomiting
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Esophageal carcinoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Lymphadenopathy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Feeding difficulties in infancy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Abnormality of the voice
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Clinodactyly of the 5th toe
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Liver neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.
|
11118037 |
2000 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DLC-1 (deleted in liver cancer 1) is a candidate tumor suppressor gene for hepatocellular carcinoma and other cancers.
|
12034501 |
2002 |
|
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
DLC-1 (deleted in liver cancer 1) is a candidate tumor suppressor gene for hepatocellular carcinoma and other cancers.
|
12034501 |
2002 |
|
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
DLC-1 was found to be deleted or downregulated in a significant number of HCCs.
|
12545165 |
2003 |
|
Liver neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
DLC-1 overexpression causes inhibition of in vitro growth of liver tumor cells and complete suppression of in vivo tumorigenicity of breast tumor cells.
|
12792785 |
2003 |
|
Adult Liver Carcinoma
|
0.070 |
Biomarker
|
disease |
BEFREE |
DLC-1 (deleted in liver cancer) gene is frequently deleted in hepatocellular carcinoma.
|
12813468 |
2003 |
|
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.070 |
Biomarker
|
disease |
BEFREE |
DLC-1 (deleted in liver cancer) gene is frequently deleted in hepatocellular carcinoma.
|
12813468 |
2003 |
|
Malignant neoplasm of liver
|
0.070 |
Biomarker
|
disease |
BEFREE |
DLC-1 (deleted in liver cancer) gene is frequently deleted in hepatocellular carcinoma.
|
12813468 |
2003 |
|
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
DLC-1 (deleted in liver cancer) gene is frequently deleted in hepatocellular carcinoma.
|
12813468 |
2003 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.
|
14661059 |
2004 |
|
Multiple Myeloma
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
DLC-1 methylation was shown in 11 of 14 (78%) patients with multiple myeloma and none of the normal controls.
|
16489177 |
2006 |
|
Carcinoma
|
0.040 |
Biomarker
|
group |
BEFREE |
DLC-1 protein was not detected in 8 of 27 (30%) prostate carcinomas and 11 of 21 (52%) benign prostatic hyperplasias.
|
16533763 |
2006 |
|
ovarian neoplasm
|
0.010 |
PosttranslationalModification
|
disease |
LHGDN |
DLEC1 promoter methylation was examined in 13 high-grade ovarian tumor tissues with DLEC1 downregulation, in which 54% of the tumors showed DLEC1 methylation.
|
16756719 |
2006 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DLC-1 (deleted in liver cancer-1) is a tumor suppressor gene for hepatocellular carcinoma and other cancers.
|
17292327 |
2007 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DLC-1 that encodes a Rho GTPase-activating protein, functions as a tumor suppressor gene and is frequently inactivated or down-regulated in several common cancers.
|
17418982 |
2007 |
|
Tumor Cell Invasion
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
|
17932950 |
2008 |